IDARUBICIN HYDROCHLORIDE

IDARUBICIN HYDROCHLORIDE was reported 1159 times

IDARUBICIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTED METASTASIS 1 0.2500
1 SEIZURE PROPHYLAXIS 1 0.2500
2 MICRODONTIA 1 0.2500
3 LIPAEMIA RETINALIS 2 0.2222
4 ADENOVIRAL ENCEPHALITIS 1 0.0909
5 PARATYPHOID FEVER 1 0.0833
6 SERTOLI-CELL-ONLY SYNDROME 1 0.0667
7 TOOTH AGENESIS 1 0.0667
8 HAEMORRHAGIC PNEUMONIA 4 0.0645
9 CULTURE NEGATIVE 1 0.0417
10 HYPODONTIA 1 0.0400
11 CYTARABINE SYNDROME 3 0.0395
12 GASTROINTESTINAL PROTOZOAL INFECTION 1 0.0385
13 T-CELL TYPE ACUTE LEUKAEMIA 6 0.0294
14 BURKHOLDERIA CEPACIA COMPLEX SEPSIS 1 0.0286
15 GENOTOXICITY 1 0.0263
16 STENOTROPHOMONAS BACTERAEMIA 2 0.0263
17 SPIROCHAETAL INFECTION 1 0.0244
18 GRANULICATELLA INFECTION 1 0.0238
19 SCALP HAEMATOMA 1 0.0233
20 RHABDOMYOSARCOMA RECURRENT 1 0.0233
21 FLAVOBACTERIUM INFECTION 1 0.0227
22 TRICHOSPORON INFECTION 9 0.0222
23 TRACHEAL ULCER 1 0.0200
24 ARTERIAL PERFORATION 1 0.0200
25 LEUKOERYTHROBLASTOSIS 2 0.0200
26 SKIN MACERATION 3 0.0196
27 CHROMOSOMAL DELETION 3 0.0189
28 STAPHYLOCOCCUS TEST 1 0.0189
29 REFRACTORINESS TO PLATELET TRANSFUSION 2 0.0183
30 CENTRAL HYPOTHYROIDISM 6 0.0181
31 NEUTROPHIL MORPHOLOGY ABNORMAL 1 0.0175
32 FUSARIUM INFECTION 12 0.0171
33 ERYTHROBLAST COUNT INCREASED 1 0.0167
34 ACUTE MONOCYTIC LEUKAEMIA 3 0.0165
35 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 1 0.0161
36 HAEMATOPOIETIC NEOPLASM 3 0.0160
37 PURE WHITE CELL APLASIA 1 0.0154
38 CHROMOSOMAL MUTATION 1 0.0147
39 DISSEMINATED TRICHOSPORONOSIS 1 0.0139
40 CLONAL HAEMATOPOIESIS 1 0.0130
41 PRIMARY HYPOGONADISM 2 0.0127
42 PURTSCHER RETINOPATHY 1 0.0122
43 GASTROINTESTINAL MUCORMYCOSIS 2 0.0120
44 CORYNEBACTERIUM BACTERAEMIA 1 0.0118
45 RETINOIC ACID SYNDROME 2 0.0116
46 CAMPYLOBACTER COLITIS 1 0.0116
47 CEREBRAL ASPERGILLOSIS 7 0.0114
48 ANTITHROMBIN III DEFICIENCY 1 0.0112
49 TISSUE INFILTRATION 3 0.0102
50 FUNGAL ENDOCARDITIS 3 0.0100
51 DEVICE RELATED BACTERAEMIA 3 0.0097
52 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 2 0.0096
53 CLONAL EVOLUTION 1 0.0096
54 DIFFERENTIATION SYNDROME 7 0.0095
55 GEOTRICHUM INFECTION 2 0.0095
56 GLUTAMATE DEHYDROGENASE INCREASED 1 0.0090
57 ZYGOMYCOSIS 4 0.0085
58 BONE MARROW NECROSIS 2 0.0085
59 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 1 0.0082
60 GRANULOCYTE COUNT DECREASED 15 0.0081
61 PHLEBOTHROMBOSIS 1 0.0078
62 SCROTAL ULCER 2 0.0077
63 RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS 1 0.0074
64 PSEUDOHYPONATRAEMIA 1 0.0073
65 CANDIDA TEST POSITIVE 3 0.0072
66 LEUKAEMIC INFILTRATION 1 0.0071
67 TRACHEAL INJURY 1 0.0068
68 HEPATOSPLENIC CANDIDIASIS 1 0.0068
69 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
70 PYOMYOSITIS 2 0.0068
71 ASPERGILLUS TEST POSITIVE 2 0.0065
72 LEUKAEMIA CUTIS 1 0.0065
73 NEOPLASM RECURRENCE 22 0.0065
74 STREPTOCOCCAL BACTERAEMIA 7 0.0064
75 LUNG DIFFUSION DISORDER 1 0.0064
76 NEUTROPENIC COLITIS 13 0.0063
77 LUMBOSACRAL RADICULOPATHY 1 0.0062
78 SUBCLAVIAN VEIN THROMBOSIS 7 0.0061
79 INFECTIVE ANEURYSM 3 0.0061
80 TOOTH MALFORMATION 1 0.0058
81 ABSCESS FUNGAL 1 0.0057
82 PULMONARY VENO-OCCLUSIVE DISEASE 4 0.0057
83 PULMONARY MUCORMYCOSIS 3 0.0057
84 ENTEROCOCCAL BACTERAEMIA 6 0.0057
85 METASTASES TO NERVOUS SYSTEM 1 0.0054
86 MYELOSUPPRESSION 195 0.0054
87 AEROMONAS INFECTION 1 0.0053
88 TONSILLITIS BACTERIAL 1 0.0052
89 SYSTEMIC MYCOSIS 6 0.0051
90 FEBRILE INFECTION 6 0.0051
91 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
92 GRANULOCYTES ABNORMAL 1 0.0050
93 STOMATITIS NECROTISING 1 0.0049
94 CHLOROMA 2 0.0047
95 ACUTE MYELOID LEUKAEMIA RECURRENT 10 0.0047
96 OROANTRAL FISTULA 1 0.0046
97 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 3 0.0046
98 STENOTROPHOMONAS INFECTION 6 0.0044
99 MUCOCUTANEOUS ULCERATION 1 0.0044
100 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 11 0.0043
101 SECOND PRIMARY MALIGNANCY 35 0.0042
102 THROMBIN TIME PROLONGED 1 0.0040
103 CHROMOSOME ANALYSIS ABNORMAL 1 0.0039
104 LEUKOPLAKIA ORAL 2 0.0039
105 ANAL INFECTION 1 0.0039
106 MYOPERICARDITIS 3 0.0038
107 PERIORBITAL CELLULITIS 2 0.0037
108 ANTITHROMBIN III DECREASED 1 0.0037
109 KLEBSIELLA SEPSIS 4 0.0035
110 CEREBRAL FUNGAL INFECTION 1 0.0035
111 ENGRAFT FAILURE 1 0.0035
112 ESCHERICHIA BACTERAEMIA 8 0.0034
113 HEPATORENAL FAILURE 2 0.0033
114 ENTEROBACTER BACTERAEMIA 1 0.0033
115 ERYTHROPENIA 1 0.0033
116 RESTRICTIVE CARDIOMYOPATHY 1 0.0033
117 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
118 CONGENITAL APLASIA 1 0.0032
119 BACILLUS INFECTION 2 0.0032
120 KLEBSIELLA BACTERAEMIA 3 0.0032
121 TYPHOID FEVER 1 0.0031
122 CEREBELLAR ATAXIA 3 0.0031
123 APLASIA 6 0.0031
124 ASPERGILLOSIS 4 0.0031
125 GENITAL INFECTION 1 0.0030
126 GIARDIASIS 1 0.0029
127 MARROW HYPERPLASIA 2 0.0029
128 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
129 TOXIC LEUKOENCEPHALOPATHY 2 0.0028
130 SOFT TISSUE INFECTION 5 0.0027
131 BRONCHOPULMONARY ASPERGILLOSIS 21 0.0027
132 ENTEROBACTER SEPSIS 1 0.0027
133 HYDROURETER 1 0.0026
134 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
135 CENTRAL NERVOUS SYSTEM INFECTION 3 0.0026
136 MEDIASTINAL MASS 1 0.0026
137 CYSTITIS VIRAL 1 0.0026
138 PROCALCITONIN INCREASED 3 0.0026
139 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
140 PNEUMONIA FUNGAL 10 0.0025
141 DYSPLASIA 3 0.0025
142 SINUSITIS FUNGAL 2 0.0025
143 DEVICE RELATED SEPSIS 5 0.0025
144 LARYNGEAL PAIN 1 0.0025
145 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
146 TUMOUR ASSOCIATED FEVER 1 0.0024
147 ACUTE MYELOID LEUKAEMIA 38 0.0024
148 TRANSPLANTATION COMPLICATION 1 0.0024
149 FEBRILE BONE MARROW APLASIA 10 0.0024
150 PSEUDOMONAL BACTERAEMIA 2 0.0023
151 FEBRILE NEUTROPENIA 152 0.0023
152 GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0023
153 REFLUX LARYNGITIS 1 0.0023
154 HYPERLEUKOCYTOSIS 2 0.0023
155 CONGESTIVE HEPATOPATHY 1 0.0022
156 MALIGNANT TRANSFORMATION 1 0.0022
157 LOCKED-IN SYNDROME 1 0.0022
158 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
159 CARDIAC DYSFUNCTION 8 0.0021
160 MASTOCYTOSIS 1 0.0021
161 BLAST CELLS PRESENT 1 0.0021
162 ANAEMIA NEONATAL 1 0.0021
163 PULMONARY SEPSIS 3 0.0021
164 HAEMATOLOGICAL INFECTION 5 0.0020
165 HYPERCALCIURIA 1 0.0020
166 MYELOID LEUKAEMIA 1 0.0020
167 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
168 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
169 MYELODYSPLASTIC SYNDROME TRANSFORMATION 1 0.0019
170 BLAST CELL COUNT INCREASED 2 0.0019
171 FUNGAEMIA 3 0.0019
172 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
173 HYPERPYREXIA 8 0.0019
174 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
175 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
176 ACINETOBACTER INFECTION 2 0.0018
177 SPLENIC RUPTURE 3 0.0018
178 NEUTROPENIC SEPSIS 13 0.0018
179 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
180 MYELODYSPLASTIC SYNDROME 26 0.0018
181 INTRAVASCULAR HAEMOLYSIS 1 0.0018
182 CYTOGENETIC ABNORMALITY 2 0.0018
183 BLOOD FIBRINOGEN DECREASED 2 0.0018
184 CARDIORENAL SYNDROME 1 0.0017
185 MEDIASTINITIS 1 0.0017
186 PAROTITIS 2 0.0017
187 ENGRAFTMENT SYNDROME 1 0.0017
188 STREPTOCOCCAL SEPSIS 2 0.0017
189 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
190 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
191 ASPERGILLUS INFECTION 11 0.0017
192 PNEUMOMEDIASTINUM 3 0.0017
193 CUTANEOUS VASCULITIS 6 0.0016
194 OTOTOXICITY 3 0.0016
195 BLOOD BILIRUBIN DECREASED 1 0.0016
196 ENTEROCOCCUS TEST POSITIVE 1 0.0015
197 MUCORMYCOSIS 4 0.0015
198 OBLITERATIVE BRONCHIOLITIS 2 0.0015
199 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
200 PSEUDOMONAS INFECTION 13 0.0015
201 GENE MUTATION 3 0.0015
202 SPUTUM ABNORMAL 1 0.0015
203 AGRANULOCYTOSIS 28 0.0015
204 HYPERBILIRUBINAEMIA 15 0.0014
205 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
206 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
207 MONOCYTE PERCENTAGE INCREASED 1 0.0014
208 VIRAL HAEMORRHAGIC CYSTITIS 1 0.0014
209 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
210 GRAFT VERSUS HOST DISEASE 10 0.0014
211 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
212 CEREBELLAR SYNDROME 3 0.0014
213 PHILADELPHIA CHROMOSOME POSITIVE 1 0.0014
214 BACTERIAL TEST POSITIVE 3 0.0013
215 CHROMATOPSIA 1 0.0013
216 PNEUMONIA PSEUDOMONAL 2 0.0013
217 COAGULATION TEST ABNORMAL 1 0.0013
218 MYELITIS 2 0.0013
219 PULMONARY MYCOSIS 1 0.0013
220 CRITICAL ILLNESS 1 0.0013
221 GOUTY ARTHRITIS 1 0.0013
222 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
223 URETERIC STENOSIS 1 0.0012
224 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
225 FUNGAL SEPSIS 1 0.0012
226 NEUTROPHIL COUNT DECREASED 49 0.0012
227 STEM CELL TRANSPLANT 3 0.0012
228 SYSTEMIC CANDIDA 3 0.0012
229 ENTEROBACTER INFECTION 2 0.0012
230 EROSIVE OESOPHAGITIS 2 0.0012
231 GINGIVAL ERYTHEMA 1 0.0012
232 AXONAL NEUROPATHY 1 0.0011
233 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
234 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
235 OLIGURIA 7 0.0011
236 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
237 NUCHAL RIGIDITY 1 0.0011
238 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
239 HEART TRANSPLANT 1 0.0011
240 PREMATURE MENOPAUSE 1 0.0011
241 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
242 COR PULMONALE 1 0.0010
243 HAEMOPHILUS INFECTION 1 0.0010
244 HYPOFIBRINOGENAEMIA 1 0.0010
245 MUCOSAL DISORDER 1 0.0010
246 HYPOGONADISM 1 0.0010
247 KLEBSIELLA INFECTION 5 0.0010
248 BONE MARROW FAILURE 20 0.0010
249 ALVEOLITIS ALLERGIC 1 0.0010
250 CAPILLARY LEAK SYNDROME 2 0.0010
251 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
252 CARDIOMYOPATHY 14 0.0009
253 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
254 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
255 IRON OVERLOAD 1 0.0009
256 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
257 TUMOUR LYSIS SYNDROME 8 0.0009
258 MYOCARDIAL INJURY 1 0.0009
259 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
260 PATHOGEN RESISTANCE 8 0.0009
261 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
262 PO2 DECREASED 1 0.0009
263 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
264 BILIRUBIN CONJUGATED INCREASED 2 0.0009
265 RESTRICTIVE PULMONARY DISEASE 1 0.0009
266 FACIAL PARESIS 3 0.0008
267 BACTERAEMIA 10 0.0008
268 HAEMATOTOXICITY 8 0.0008
269 FULL BLOOD COUNT INCREASED 1 0.0008
270 PNEUMONIA INFLUENZAL 1 0.0008
271 ESCHERICHIA TEST POSITIVE 1 0.0008
272 HEPATITIS CHOLESTATIC 5 0.0008
273 VENOOCCLUSIVE DISEASE 2 0.0008
274 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
275 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
276 ABDOMINAL INFECTION 2 0.0008
277 HEPATOSPLENOMEGALY 2 0.0008
278 APLASTIC ANAEMIA 4 0.0008
279 RECURRENT CANCER 3 0.0007
280 CYTOPENIA 9 0.0007
281 URETERIC OBSTRUCTION 1 0.0007
282 THROMBOCYTOPENIC PURPURA 1 0.0007
283 FUNGAL INFECTION 24 0.0007
284 H1N1 INFLUENZA 1 0.0007
285 MYELITIS TRANSVERSE 1 0.0007
286 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
287 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
288 INTENSIVE CARE 1 0.0007
289 GRANULOCYTOPENIA 4 0.0007
290 PNEUMATOSIS INTESTINALIS 2 0.0007
291 HERPES VIRUS INFECTION 4 0.0007
292 NONINFECTIVE GINGIVITIS 1 0.0007
293 ADENOVIRUS INFECTION 2 0.0007
294 SUBARACHNOID HAEMORRHAGE 7 0.0007
295 GASTROINTESTINAL NECROSIS 2 0.0007
296 NEUROTOXICITY 12 0.0007
297 HYPERTRIGLYCERIDAEMIA 4 0.0007
298 BILIARY DILATATION 1 0.0007
299 APRAXIA 1 0.0007
300 HAEMORRHAGE INTRACRANIAL 10 0.0007
301 BLOOD CULTURE POSITIVE 2 0.0007
302 SUSPECTED OFF LABEL USE 3 0.0007
303 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
304 DUODENITIS 2 0.0007
305 MUCOSAL INFLAMMATION 17 0.0006
306 PULMONARY HAEMORRHAGE 5 0.0006
307 MEGACOLON 1 0.0006
308 EOSINOPHILIC PNEUMONIA 2 0.0006
309 NEOPLASM PROGRESSION 22 0.0006
310 LIVER ABSCESS 2 0.0006
311 SKULL FRACTURE 1 0.0006
312 BACTERIAL SEPSIS 2 0.0006
313 PANCYTOPENIA 34 0.0006
314 HYPERVOLAEMIA 3 0.0006
315 SYSTEMIC INFECTION 1 0.0006
316 TROPONIN I INCREASED 1 0.0006
317 SEPTIC SHOCK 26 0.0006
318 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
319 FULL BLOOD COUNT DECREASED 12 0.0006
320 TONSILLAR HYPERTROPHY 1 0.0006
321 ENTERITIS INFECTIOUS 1 0.0006
322 ENDOCARDITIS 3 0.0006
323 BRONCHOPNEUMONIA 2 0.0006
324 TEMPERATURE INTOLERANCE 6 0.0006
325 MYCOBACTERIAL INFECTION 1 0.0006
326 ACUTE SINUSITIS 1 0.0006
327 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
328 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
329 ERYTHEMA NODOSUM 2 0.0006
330 JAUNDICE CHOLESTATIC 2 0.0006
331 DRUG ERUPTION 10 0.0006
332 RETINAL HAEMORRHAGE 4 0.0006
333 INDURATION 1 0.0006
334 MONOPARESIS 1 0.0006
335 OPPORTUNISTIC INFECTION 1 0.0005
336 HEPATIC FUNCTION ABNORMAL 20 0.0005
337 ACUTE PULMONARY OEDEMA 3 0.0005
338 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
339 CYSTOID MACULAR OEDEMA 1 0.0005
340 HYPOPROTEINAEMIA 1 0.0005
341 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
342 MYOCARDITIS 6 0.0005
343 ENTEROCOLITIS 3 0.0005
344 GALLBLADDER INJURY 1 0.0005
345 ORAL INFECTION 2 0.0005
346 MULTI-ORGAN DISORDER 1 0.0005
347 PLATELET COUNT DECREASED 54 0.0005
348 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
349 TOXIC SKIN ERUPTION 5 0.0005
350 HEPATOTOXICITY 11 0.0005
351 DERMATITIS ACNEIFORM 3 0.0005
352 HICCUPS 4 0.0005
353 CYTOMEGALOVIRUS INFECTION 8 0.0005
354 COAGULOPATHY 8 0.0005
355 IMMUNODEFICIENCY 7 0.0005
356 CATHETER SITE ERYTHEMA 1 0.0005
357 PROCTALGIA 3 0.0005
358 RESPIRATORY FAILURE 34 0.0005
359 HYPERPHOSPHATAEMIA 1 0.0005
360 PERIODONTITIS 1 0.0005
361 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
362 PARONYCHIA 2 0.0005
363 LUNG INFILTRATION 4 0.0005
364 CARDIAC FAILURE ACUTE 3 0.0004
365 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
366 RASH MACULO-PAPULAR 10 0.0004
367 COLITIS 17 0.0004
368 CARDIOTOXICITY 4 0.0004
369 COLITIS ISCHAEMIC 3 0.0004
370 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
371 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
372 PAPILLOEDEMA 2 0.0004
373 HIDRADENITIS 4 0.0004
374 SKIN LESION 12 0.0004
375 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
376 SINUS PAIN 1 0.0004
377 DRUG RESISTANCE 11 0.0004
378 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
379 PRURITUS GENITAL 1 0.0004
380 HEPATOCELLULAR INJURY 6 0.0004
381 SUBDURAL HAEMATOMA 6 0.0004
382 GASTROINTESTINAL TOXICITY 2 0.0004
383 ENTEROCOCCAL INFECTION 2 0.0004
384 PANNICULITIS 1 0.0004
385 THROMBOTIC MICROANGIOPATHY 4 0.0004
386 TRANSPLANT FAILURE 1 0.0004
387 BLOOD BILIRUBIN INCREASED 11 0.0004
388 HYPOPHOSPHATAEMIA 3 0.0004
389 DERMATITIS EXFOLIATIVE 2 0.0004
390 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
391 ABNORMAL UTERINE BLEEDING 1 0.0004
392 EJECTION FRACTION DECREASED 6 0.0004
393 CATHETER SITE PAIN 1 0.0004
394 PETECHIAE 4 0.0004
395 HYPERSENSITIVITY VASCULITIS 1 0.0004
396 BACTERIAL INFECTION 7 0.0004
397 NEUTROPENIA 51 0.0004
398 LARYNGOSPASM 1 0.0004
399 ABDOMINAL RIGIDITY 1 0.0004
400 LARGE INTESTINAL ULCER 1 0.0004
401 INFECTION 53 0.0004
402 ULCERATIVE KERATITIS 1 0.0004
403 RASH MORBILLIFORM 1 0.0004
404 ORAL HERPES 7 0.0004
405 LUNG CONSOLIDATION 1 0.0004
406 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
407 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
408 NEPHROPATHY TOXIC 4 0.0004
409 RENAL TUBULAR DISORDER 1 0.0004
410 OXYGEN SATURATION ABNORMAL 1 0.0004
411 FACIAL PARALYSIS 3 0.0004
412 RESPIRATORY SYMPTOM 1 0.0004
413 NEUROLOGICAL SYMPTOM 2 0.0003
414 SEPSIS 39 0.0003
415 PLEURAL EFFUSION 21 0.0003
416 ESCHERICHIA SEPSIS 1 0.0003
417 HAEMOTHORAX 1 0.0003
418 ELECTROLYTE IMBALANCE 4 0.0003
419 HEPATITIS FULMINANT 1 0.0003
420 PULMONARY MASS 5 0.0003
421 BRAIN HERNIATION 1 0.0003
422 GASTROINTESTINAL INFECTION 3 0.0003
423 MIXED LIVER INJURY 1 0.0003
424 PNEUMONIA BACTERIAL 3 0.0003
425 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
426 APPENDICITIS 3 0.0003
427 LEUKAEMIA 3 0.0003
428 NON-CARDIAC CHEST PAIN 1 0.0003
429 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
430 PNEUMOTHORAX 5 0.0003
431 HEPATITIS B REACTIVATION 1 0.0003
432 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
433 HEPATIC CYTOLYSIS 4 0.0003
434 HYPOXIA 11 0.0003
435 VENTRICULAR HYPOKINESIA 1 0.0003
436 SINUS BRADYCARDIA 3 0.0003
437 LISTLESS 1 0.0003
438 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
439 HEPATIC FAILURE 9 0.0003
440 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
441 CLOSTRIDIAL INFECTION 1 0.0003
442 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
443 APLASIA PURE RED CELL 1 0.0003
444 LEFT VENTRICULAR FAILURE 1 0.0003
445 MULTI-ORGAN FAILURE 5 0.0003
446 PYREXIA 100 0.0003
447 HYPOPNOEA 1 0.0003
448 HYPERREFLEXIA 1 0.0003
449 HAEMOPTYSIS 8 0.0003
450 RIGHT VENTRICULAR FAILURE 2 0.0003
451 NECROTISING FASCIITIS 1 0.0003
452 DUODENAL ULCER 2 0.0003
453 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
454 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
455 FIBRIN D DIMER INCREASED 1 0.0003
456 HAEMORRHAGIC DIATHESIS 1 0.0003
457 CONJUNCTIVAL HYPERAEMIA 1 0.0003
458 VISUAL FIELD DEFECT 2 0.0003
459 C-REACTIVE PROTEIN INCREASED 10 0.0003
460 BLOOD PHOSPHORUS DECREASED 1 0.0003
461 MELAENA 6 0.0003
462 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
463 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
464 SKIN INFECTION 3 0.0003
465 HAEMODYNAMIC INSTABILITY 2 0.0003
466 SHOCK 6 0.0003
467 HYPOKALAEMIA 12 0.0003
468 THROMBOCYTOPENIA 29 0.0003
469 HYPOALBUMINAEMIA 2 0.0003
470 RHINOVIRUS INFECTION 1 0.0003
471 CARDIOPULMONARY FAILURE 1 0.0003
472 GASTROINTESTINAL INFLAMMATION 2 0.0003
473 DRUG-INDUCED LIVER INJURY 8 0.0003
474 PRODUCTIVE COUGH 12 0.0003
475 OESOPHAGEAL CANDIDIASIS 1 0.0003
476 AZOTAEMIA 1 0.0003
477 CANDIDIASIS 1 0.0002
478 FUNGAL SKIN INFECTION 1 0.0002
479 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
480 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
481 HYPERURICAEMIA 1 0.0002
482 ILEUS 3 0.0002
483 CARDIAC FAILURE 19 0.0002
484 PULMONARY TUBERCULOSIS 1 0.0002
485 PSYCHOLOGICAL TRAUMA 2 0.0002
486 HEPATIC LESION 1 0.0002
487 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
488 IMMUNOSUPPRESSION 2 0.0002
489 GINGIVAL SWELLING 1 0.0002
490 ILEUS PARALYTIC 1 0.0002
491 RASH PAPULAR 5 0.0002
492 MENINGITIS ASEPTIC 1 0.0002
493 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
494 OROPHARYNGEAL DISCOMFORT 2 0.0002
495 LEUKOCYTOSIS 4 0.0002
496 DISEASE COMPLICATION 1 0.0002
497 IMMUNE THROMBOCYTOPENIA 1 0.0002
498 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
499 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
500 PERICARDIAL EFFUSION 5 0.0002
501 GASTRITIS EROSIVE 1 0.0002
502 CARDIAC TAMPONADE 1 0.0002
503 CHOLESTASIS 4 0.0002
504 SEROTONIN SYNDROME 4 0.0002
505 RENAL TUBULAR NECROSIS 2 0.0002
506 ENCEPHALOPATHY 5 0.0002
507 HEPATOMEGALY 2 0.0002
508 STAPHYLOCOCCAL SEPSIS 1 0.0002
509 ORGANISING PNEUMONIA 1 0.0002
510 HYPERNATRAEMIA 1 0.0002
511 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
512 FLUID INTAKE REDUCED 1 0.0002
513 BRAIN INJURY 2 0.0002
514 EMPHYSEMA 2 0.0002
515 TOXIC ENCEPHALOPATHY 1 0.0002
516 DEVICE RELATED INFECTION 3 0.0002
517 HAEMOGLOBIN DECREASED 20 0.0002
518 BLOOD LACTIC ACID INCREASED 1 0.0002
519 SERUM FERRITIN INCREASED 1 0.0002
520 DISEASE RECURRENCE 9 0.0002
521 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
522 PNEUMONIA 61 0.0002
523 LIVER FUNCTION TEST INCREASED 4 0.0002
524 JAUNDICE 5 0.0002
525 ANAL ABSCESS 1 0.0002
526 CHEILITIS 1 0.0002
527 VENTRICULAR FIBRILLATION 2 0.0002
528 STREPTOCOCCAL INFECTION 1 0.0002
529 INTRACRANIAL PRESSURE INCREASED 1 0.0002
530 INTERMENSTRUAL BLEEDING 1 0.0002
531 CANDIDA INFECTION 3 0.0002
532 CIRCULATORY COLLAPSE 3 0.0002
533 PERONEAL NERVE PALSY 1 0.0002
534 GENERALISED ERYTHEMA 1 0.0002
535 MYOCARDIAL ISCHAEMIA 2 0.0002
536 RED BLOOD CELL COUNT DECREASED 5 0.0002
537 RALES 1 0.0002
538 LIVER FUNCTION TEST ABNORMAL 5 0.0002
539 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
540 HYPOVOLAEMIA 1 0.0002
541 CHOLECYSTITIS 2 0.0002
542 ENDOPHTHALMITIS 1 0.0002
543 HEPATITIS B 1 0.0002
544 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
545 CARDIOMEGALY 2 0.0002
546 LARYNGEAL OEDEMA 1 0.0002
547 GENERALISED OEDEMA 2 0.0002
548 CHOLANGITIS 1 0.0002
549 HEPATIC STEATOSIS 3 0.0002
550 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
551 DERMATITIS ALLERGIC 2 0.0002
552 LIVER DISORDER 7 0.0002
553 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
554 ENTERITIS 1 0.0002
555 HEPATITIS ACUTE 1 0.0002
556 RESPIRATORY TRACT INFECTION 4 0.0002
557 PLATELET COUNT INCREASED 2 0.0002
558 ANAEMIA 29 0.0002
559 IMMUNE SYSTEM DISORDER 2 0.0002
560 TACHYPNOEA 2 0.0001
561 GINGIVAL BLEEDING 2 0.0001
562 ECCHYMOSIS 1 0.0001
563 INTERSTITIAL LUNG DISEASE 7 0.0001
564 ENCEPHALITIS 1 0.0001
565 LARGE INTESTINE PERFORATION 1 0.0001
566 HYPERTRANSAMINASAEMIA 1 0.0001
567 HYPOMAGNESAEMIA 2 0.0001
568 PAPULE 1 0.0001
569 SINUS TACHYCARDIA 2 0.0001
570 BRONCHOSPASM 2 0.0001
571 IMPAIRED QUALITY OF LIFE 2 0.0001
572 FAECES SOFT 1 0.0001
573 UTERINE LEIOMYOMA 1 0.0001
574 ORAL DISORDER 1 0.0001
575 MOUTH HAEMORRHAGE 1 0.0001
576 ASCITES 4 0.0001
577 BLINDNESS TRANSIENT 1 0.0001
578 TRANSAMINASES INCREASED 3 0.0001
579 HYDRONEPHROSIS 1 0.0001
580 PANCREATITIS ACUTE 3 0.0001
581 GENERAL SYMPTOM 1 0.0001
582 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
583 TROPONIN INCREASED 1 0.0001
584 ACIDOSIS 1 0.0001
585 ATRIOVENTRICULAR BLOCK 1 0.0001
586 RENAL DISORDER 6 0.0001
587 THERAPY PARTIAL RESPONDER 2 0.0001
588 TORSADE DE POINTES 1 0.0001
589 BLOOD ALBUMIN DECREASED 1 0.0001
590 LOW BIRTH WEIGHT BABY 1 0.0001
591 GINGIVAL PAIN 1 0.0001
592 METABOLIC ACIDOSIS 4 0.0001
593 SHOCK HAEMORRHAGIC 1 0.0001
594 BLOOD CREATININE INCREASED 8 0.0001
595 LIVER INJURY 3 0.0001
596 ESCHERICHIA INFECTION 1 0.0001
597 STAPHYLOCOCCAL INFECTION 4 0.0001
598 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
599 OSTEONECROSIS OF JAW 3 0.0001
600 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
601 RHABDOMYOLYSIS 5 0.0001
602 LIVE BIRTH 1 0.0001
603 BLOOD UREA INCREASED 2 0.0001
604 CELLULITIS 6 0.0001
605 PERICARDITIS 2 0.0001
606 HAEMATEMESIS 3 0.0001
607 ANURIA 1 0.0001
608 PURPURA 1 0.0001
609 RESPIRATORY RATE INCREASED 1 0.0001
610 SEIZURE 13 0.0001
611 FACIAL PAIN 1 0.0001
612 PULMONARY OEDEMA 5 0.0001
613 URINARY TRACT INFECTION 19 0.0001
614 BRAIN NEOPLASM 1 0.0001
615 CONJUNCTIVITIS 2 0.0001
616 ERYTHEMA MULTIFORME 1 0.0001
617 HEPATIC ENCEPHALOPATHY 1 0.0001
618 SPUTUM DISCOLOURED 1 0.0001
619 RENAL FAILURE 14 0.0001
620 PULMONARY EMBOLISM 10 0.0001
621 RASH ERYTHEMATOUS 5 0.0001
622 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
623 ATELECTASIS 1 0.0001
624 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
625 PULMONARY HYPERTENSION 2 0.0001
626 MOUTH ULCERATION 2 0.0001
627 RETCHING 2 0.0001
628 EPISTAXIS 7 0.0001
629 WOUND INFECTION 1 0.0001
630 INTESTINAL PERFORATION 1 0.0001
631 STATUS EPILEPTICUS 1 0.0001
632 HAEMATURIA 3 0.0001
633 HERPES ZOSTER 5 0.0001
634 EYELID OEDEMA 1 0.0001
635 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
636 ATAXIA 1 0.0001
637 MYOCLONUS 1 0.0001
638 POLYNEUROPATHY 1 0.0001
639 RENAL IMPAIRMENT 7 0.0001
640 DRUG EFFECT INCOMPLETE 3 0.0001
641 ADRENAL INSUFFICIENCY 1 0.0001
642 HYPERGLYCAEMIA 3 0.0001
643 NO THERAPEUTIC RESPONSE 1 0.0001
644 ABNORMAL WEIGHT GAIN 1 0.0001
645 PHARYNGITIS 1 0.0001
646 DYSARTHRIA 3 0.0001
647 BRAIN OEDEMA 1 0.0001
648 ANAPHYLACTIC SHOCK 2 0.0001
649 RASH GENERALISED 2 0.0001
650 VOMITING 36 0.0001
651 GASTRITIS 2 0.0001
652 SARS-COV-2 TEST POSITIVE 1 0.0001
653 PANCREATITIS 4 0.0001
654 OFF LABEL USE 66 0.0001
655 JOINT RANGE OF MOTION DECREASED 1 0.0001
656 PNEUMONITIS 2 0.0001
657 HEPATIC ENZYME INCREASED 5 0.0001
658 ACUTE HEPATIC FAILURE 1 0.0001
659 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
660 DIVERTICULITIS 2 0.0001
661 ACUTE KIDNEY INJURY 11 0.0001
662 COORDINATION ABNORMAL 1 0.0001
663 DEVICE OCCLUSION 1 0.0001
664 LYMPHOPENIA 1 0.0001
665 RENAL FAILURE ACUTE 3 0.0001
666 CARDIOGENIC SHOCK 1 0.0001
667 ASTHENIA 26 0.0001
668 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
669 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
670 THERAPY NON-RESPONDER 3 0.0001
671 PREMATURE BABY 2 0.0001
672 APHASIA 2 0.0001
673 STOMATITIS 4 0.0001
674 DRUG ADMINISTRATION ERROR 2 0.0001
675 OROPHARYNGEAL PAIN 6 0.0001
676 DECREASED APPETITE 15 0.0001
677 LUNG INFECTION 1 0.0001
678 SCIATICA 1 0.0001
679 ATRIAL FIBRILLATION 6 0.0001
680 DEEP VEIN THROMBOSIS 4 0.0001
681 CARDIAC ARREST 5 0.0001
682 VIRAL INFECTION 2 0.0001
683 LEUKOPENIA 3 0.0001
684 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
685 CHILLS 7 0.0001
686 NAUSEA 46 0.0001
687 LOCAL SWELLING 1 0.0001
688 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
689 EOSINOPHILIA 1 0.0001
690 HYPERKALAEMIA 2 0.0001
691 CEREBRAL HAEMORRHAGE 2 0.0001
692 OSTEOMYELITIS 1 0.0001
693 RASH 24 0.0001
694 END STAGE RENAL DISEASE 1 0.0001
695 RESTLESSNESS 2 0.0001
696 OXYGEN SATURATION DECREASED 3 0.0001
697 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
698 PHOTOPHOBIA 1 0.0001
699 HYPOCALCAEMIA 1 0.0001
700 BLOOD URINE PRESENT 1 0.0001
701 CONDITION AGGRAVATED 16 0.0001
702 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
703 ACUTE RESPIRATORY FAILURE 1 0.0001
704 ERUCTATION 1 0.0001
705 HAEMORRHOIDS 1 0.0001
706 MENORRHAGIA 1 0.0001
707 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
708 ABNORMAL BEHAVIOUR 2 0.0001
709 COUGH 14 0.0000
710 DEATH 43 0.0000
711 PRODUCT ADMINISTRATION ERROR 1 0.0000
712 FEEDING DISORDER 1 0.0000
713 BLINDNESS 2 0.0000
714 BODY TEMPERATURE INCREASED 1 0.0000
715 CHEST DISCOMFORT 5 0.0000
716 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
717 PERITONITIS 1 0.0000
718 TREATMENT FAILURE 4 0.0000
719 ABDOMINAL DISTENSION 5 0.0000
720 TOXICITY TO VARIOUS AGENTS 8 0.0000
721 EATING DISORDER 1 0.0000
722 RHINORRHOEA 3 0.0000
723 BLOOD PRESSURE DECREASED 3 0.0000
724 TACHYCARDIA 4 0.0000
725 DRUG INTERACTION 7 0.0000
726 ERYTHEMA 9 0.0000
727 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
728 ARRHYTHMIA 2 0.0000
729 LOCALISED INFECTION 1 0.0000
730 DIARRHOEA 26 0.0000
731 EXTRAPYRAMIDAL DISORDER 1 0.0000
732 PNEUMONIA ASPIRATION 1 0.0000
733 HYPOPHAGIA 1 0.0000
734 PALLOR 1 0.0000
735 MOOD ALTERED 1 0.0000
736 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
737 RESPIRATORY ARREST 1 0.0000
738 HAEMATOCHEZIA 2 0.0000
739 RESPIRATORY DISTRESS 1 0.0000
740 WOUND 1 0.0000
741 HYPONATRAEMIA 2 0.0000
742 CONVULSION 2 0.0000
743 HYPOTENSION 7 0.0000
744 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
745 ABDOMINAL PAIN 8 0.0000
746 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
747 PSYCHOTIC DISORDER 1 0.0000
748 URINARY INCONTINENCE 1 0.0000
749 RESPIRATORY DISORDER 1 0.0000
750 OEDEMA PERIPHERAL 4 0.0000
751 EPILEPSY 1 0.0000
752 EXPOSURE DURING PREGNANCY 2 0.0000
753 NERVOUS SYSTEM DISORDER 1 0.0000
754 CONFUSIONAL STATE 5 0.0000
755 LACTIC ACIDOSIS 1 0.0000
756 CHOLELITHIASIS 1 0.0000
757 OSTEONECROSIS 1 0.0000
758 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
759 ABDOMINAL PAIN UPPER 6 0.0000
760 DELIRIUM 1 0.0000
761 HAEMORRHAGE 3 0.0000
762 ANXIETY 8 0.0000
763 DIZZINESS 14 0.0000
764 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
765 DRUG INEFFECTIVE 36 0.0000
766 DYSURIA 1 0.0000
767 BRONCHITIS 2 0.0000
768 PRODUCT USE ISSUE 5 0.0000
769 INTESTINAL OBSTRUCTION 1 0.0000
770 MUSCULAR WEAKNESS 3 0.0000
771 DIABETES MELLITUS 2 0.0000
772 DISEASE PROGRESSION 3 0.0000
773 DISORIENTATION 1 0.0000
774 DRY MOUTH 2 0.0000
775 VISUAL IMPAIRMENT 3 0.0000
776 CARDIO-RESPIRATORY ARREST 1 0.0000
777 HYPERTENSION 5 0.0000
778 MYALGIA 4 0.0000
779 PRURITUS 9 0.0000
780 RECTAL HAEMORRHAGE 1 0.0000
781 BALANCE DISORDER 2 0.0000
782 VAGINAL HAEMORRHAGE 1 0.0000
783 MENTAL DISORDER 1 0.0000
784 DYSPNOEA 13 0.0000
785 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
786 COLITIS ULCERATIVE 1 0.0000
787 GASTROINTESTINAL DISORDER 2 0.0000
788 VISION BLURRED 3 0.0000
789 SKIN DISCOLOURATION 1 0.0000
790 SWELLING 2 0.0000
791 NEUROPATHY PERIPHERAL 2 0.0000
792 ALOPECIA 4 0.0000
793 DYSPEPSIA 2 0.0000
794 HEART RATE INCREASED 2 0.0000
795 INFLAMMATION 1 0.0000
796 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
797 HEADACHE 12 0.0000
798 MUSCULOSKELETAL PAIN 1 0.0000
799 PARAESTHESIA 3 0.0000
800 INSOMNIA 5 0.0000
801 RASH PRURITIC 1 0.0000
802 OEDEMA 1 0.0000
803 CONSTIPATION 4 0.0000
804 NECK PAIN 1 0.0000
805 ABDOMINAL DISCOMFORT 3 0.0000
806 BLISTER 1 0.0000
807 FLATULENCE 1 0.0000
808 LETHARGY 1 0.0000
809 COVID-19 3 0.0000
810 PALPITATIONS 2 0.0000
811 PAIN IN EXTREMITY 5 0.0000
812 EMOTIONAL DISTRESS 2 0.0000
813 THERAPEUTIC RESPONSE DECREASED 1 0.0000
814 ILL-DEFINED DISORDER 1 0.0000
815 VERTIGO 1 0.0000
816 DISCOMFORT 1 0.0000
817 LOSS OF CONSCIOUSNESS 2 0.0000
818 AMNESIA 1 0.0000
819 SWELLING FACE 1 0.0000
820 DEHYDRATION 2 0.0000
821 SLEEP DISORDER 1 0.0000
822 AGITATION 1 0.0000
823 DYSGEUSIA 1 0.0000
824 WEIGHT INCREASED 3 0.0000
825 HALLUCINATION 1 0.0000
826 HOT FLUSH 1 0.0000
827 UNEVALUABLE EVENT 1 0.0000
828 BLOOD PRESSURE INCREASED 2 0.0000
829 CARDIAC FAILURE CONGESTIVE 1 0.0000
830 THROMBOSIS 1 0.0000
831 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
832 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
833 TREMOR 2 0.0000
834 SKIN EXFOLIATION 1 0.0000
835 CEREBROVASCULAR ACCIDENT 2 0.0000
836 ADVERSE EVENT 1 0.0000
837 DYSPHAGIA 1 0.0000
838 CONTUSION 1 0.0000
839 DRUG INTOLERANCE 1 0.0000
840 FATIGUE 8 0.0000
841 SYNCOPE 1 0.0000
842 SOMNOLENCE 2 0.0000
843 SINUSITIS 1 0.0000
844 MALAISE 4 0.0000
845 INFLUENZA 1 0.0000
846 PAIN 5 0.0000
847 HYPERHIDROSIS 1 0.0000
848 FALL 2 0.0000
849 URTICARIA 1 0.0000
850 MYOCARDIAL INFARCTION 1 0.0000
851 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
852 CHEST PAIN 1 0.0000
853 HYPERSENSITIVITY 1 0.0000
854 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
855 INJECTION SITE PAIN 1 0.0000
856 ARTHRALGIA 1 0.0000